Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Insights, Forecast to 2028

Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Insights, Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Pertuzumab
1.2.3 Trastuzumab
1.3 Market by Application
1.3.1 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Combination Therapy
1.3.3 Mono Therapy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Perspective (2017-2028)
2.2 Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Growth Trends by Region
2.2.1 Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Historic Market Size by Region (2017-2022)
2.2.3 Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Forecasted Market Size by Region (2023-2028)
2.3 Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Dynamics
2.3.1 Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Industry Trends
2.3.2 Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Drivers
2.3.3 Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Challenges
2.3.4 Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Players by Revenue
3.1.1 Global Top Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Players by Revenue (2017-2022)
3.1.2 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Revenue Market Share by Players (2017-2022)
3.2 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Revenue
3.4 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Concentration Ratio
3.4.1 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Revenue in 2021
3.5 Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Key Players Head office and Area Served
3.6 Key Players Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Product Solution and Service
3.7 Date of Enter into Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Breakdown Data by Type
4.1 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Historic Market Size by Type (2017-2022)
4.2 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Forecasted Market Size by Type (2023-2028)
5 Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Breakdown Data by Application
5.1 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Historic Market Size by Application (2017-2022)
5.2 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size (2017-2028)
6.2 North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type
6.2.1 North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2017-2022)
6.2.2 North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2023-2028)
6.2.3 North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Type (2017-2028)
6.3 North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application
6.3.1 North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2017-2022)
6.3.2 North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2023-2028)
6.3.3 North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Application (2017-2028)
6.4 North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country
6.4.1 North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2017-2022)
6.4.2 North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size (2017-2028)
7.2 Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type
7.2.1 Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2017-2022)
7.2.2 Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2023-2028)
7.2.3 Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Type (2017-2028)
7.3 Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application
7.3.1 Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2017-2022)
7.3.2 Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2023-2028)
7.3.3 Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Application (2017-2028)
7.4 Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country
7.4.1 Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2017-2022)
7.4.2 Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size (2017-2028)
8.2 Asia-Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type
8.2.1 Asia-Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Type (2017-2028)
8.3 Asia-Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application
8.3.1 Asia-Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Application (2017-2028)
8.4 Asia-Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Region
8.4.1 Asia-Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size (2017-2028)
9.2 Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type
9.2.1 Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2017-2022)
9.2.2 Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2023-2028)
9.2.3 Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Type (2017-2028)
9.3 Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application
9.3.1 Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2017-2022)
9.3.2 Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2023-2028)
9.3.3 Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Application (2017-2028)
9.4 Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country
9.4.1 Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2017-2022)
9.4.2 Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size (2017-2028)
10.2 Middle East & Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type
10.2.1 Middle East & Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Type (2017-2028)
10.3 Middle East & Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application
10.3.1 Middle East & Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Application (2017-2028)
10.4 Middle East & Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country
10.4.1 Middle East & Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Introduction
11.1.4 Roche Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2017-2022)
11.1.5 Roche Recent Developments
11.2 BOC Sciences
11.2.1 BOC Sciences Company Details
11.2.2 BOC Sciences Business Overview
11.2.3 BOC Sciences Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Introduction
11.2.4 BOC Sciences Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2017-2022)
11.2.5 BOC Sciences Recent Developments
11.3 LGM Pharma
11.3.1 LGM Pharma Company Details
11.3.2 LGM Pharma Business Overview
11.3.3 LGM Pharma Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Introduction
11.3.4 LGM Pharma Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2017-2022)
11.3.5 LGM Pharma Recent Developments
11.4 Biotechnica Pharma Global
11.4.1 Biotechnica Pharma Global Company Details
11.4.2 Biotechnica Pharma Global Business Overview
11.4.3 Biotechnica Pharma Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Introduction
11.4.4 Biotechnica Pharma Global Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2017-2022)
11.4.5 Biotechnica Pharma Global Recent Developments
11.5 KinBio
11.5.1 KinBio Company Details
11.5.2 KinBio Business Overview
11.5.3 KinBio Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Introduction
11.5.4 KinBio Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2017-2022)
11.5.5 KinBio Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Introduction
11.6.4 Merck Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2017-2022)
11.6.5 Merck Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Pertuzumab
Table 3. Key Players of Trastuzumab
Table 4. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Region (2017-2022)
Table 8. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Region (2023-2028)
Table 10. Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Trends
Table 11. Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Drivers
Table 12. Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Challenges
Table 13. Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Restraints
Table 14. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Revenue Share by Players (2017-2022)
Table 16. Global Top Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer as of 2021)
Table 17. Ranking of Global Top Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Product Solution and Service
Table 21. Date of Enter into Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Revenue Market Share by Type (2017-2022)
Table 25. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Revenue Market Share by Type (2023-2028)
Table 27. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Revenue Share by Application (2017-2022)
Table 29. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Revenue Share by Application (2023-2028)
Table 31. North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Product
Table 64. Roche Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2017-2022) & (US$ Million)
Table 65. Roche Recent Developments
Table 66. BOC Sciences Company Details
Table 67. BOC Sciences Business Overview
Table 68. BOC Sciences Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Product
Table 69. BOC Sciences Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2017-2022) & (US$ Million)
Table 70. BOC Sciences Recent Developments
Table 71. LGM Pharma Company Details
Table 72. LGM Pharma Business Overview
Table 73. LGM Pharma Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Product
Table 74. LGM Pharma Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2017-2022) & (US$ Million)
Table 75. LGM Pharma Recent Developments
Table 76. Biotechnica Pharma Global Company Details
Table 77. Biotechnica Pharma Global Business Overview
Table 78. Biotechnica Pharma Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Product
Table 79. Biotechnica Pharma Global Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2017-2022) & (US$ Million)
Table 80. Biotechnica Pharma Global Recent Developments
Table 81. KinBio Company Details
Table 82. KinBio Business Overview
Table 83. KinBio Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Product
Table 84. KinBio Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2017-2022) & (US$ Million)
Table 85. KinBio Recent Developments
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Product
Table 89. Merck Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2017-2022) & (US$ Million)
Table 90. Merck Recent Developments
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Type: 2021 VS 2028
Figure 2. Pertuzumab Features
Figure 3. Trastuzumab Features
Figure 4. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Application: 2021 VS 2028
Figure 5. Combination Therapy Case Studies
Figure 6. Mono Therapy Case Studies
Figure 7. Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Report Years Considered
Figure 8. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Region: 2021 VS 2028
Figure 11. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Players in 2021
Figure 12. Global Top Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Revenue in 2021
Figure 14. North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY (2017-2028) & (US$ Million)
Figure 15. North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Market Share by Type (2017-2028)
Figure 16. North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Market Share by Application (2017-2028)
Figure 17. North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Share by Country (2017-2028)
Figure 18. United States Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY (2017-2028) & (US$ Million)
Figure 21. Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Market Share by Type (2017-2028)
Figure 22. Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Market Share by Application (2017-2028)
Figure 23. Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Share by Country (2017-2028)
Figure 24. Germany Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY (2017-2028) & (US$ Million)
Figure 31. Asia Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Market Share by Type (2017-2028)
Figure 32. Asia Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Market Share by Application (2017-2028)
Figure 33. Asia Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Share by Region (2017-2028)
Figure 34. China Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 40. Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY (2017-2028) & (US$ Million)
Figure 41. Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Market Share by Type (2017-2028)
Figure 42. Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Market Share by Application (2017-2028)
Figure 43. Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Share by Country (2017-2028)
Figure 44. Mexico Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Middle East and Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Market Share by Type (2017-2028)
Figure 48. Middle East and Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Market Share by Application (2017-2028)
Figure 49. Middle East and Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Share by Country (2017-2028)
Figure 50. Turkey Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. UAE Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Roche Revenue Growth Rate in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2017-2022)
Figure 54. BOC Sciences Revenue Growth Rate in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2017-2022)
Figure 55. LGM Pharma Revenue Growth Rate in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2017-2022)
Figure 56. Biotechnica Pharma Global Revenue Growth Rate in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2017-2022)
Figure 57. KinBio Revenue Growth Rate in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2017-2022)
Figure 58. Merck Revenue Growth Rate in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2017-2022)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs